Wire · opportunities
Johnson & Johnson MedTech nabs Monarch Quest 3 update for lung cancer detection
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 21 August 2026 · Fusion42 review
Johnson & Johnson MedTech received FDA 510(k) clearance for Monarch Quest 3, the latest software update for its robotic bronchoscopy platform used to detect lung cancer. The update improves navigation accuracy, integrates AI for nodule segmentation, and includes a digital ecosystem for clinical collaboration.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 17 Aug 2026 and 18 Aug 2026.
◆ ◆ The Wire takeaway
You can now leverage improved robotic bronchoscopy tools for earlier and more accurate lung cancer detection with integrated AI features, increasing your competitive edge in diagnostic tech. Prepare to engage clinical teams keen on digital collaboration and enhanced surgical planning workflows.
◆ Coverage
4 sources · first reported 17 Aug 2026 · latest 18 Aug 2026
◆ Related on Wire
◆ Topics